Drug Information

Drug General Information
Drug ID
D01DAU
Former ID
DNC008911
Drug Name
4-(3-Pent-1-ynyl-benzyl)-1H-imidazole
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529437]
Formula
C15H16N2
Canonical SMILES
CCCC#CC1=CC(=CC=C1)CC2=CN=CN2
InChI
1S/C15H16N2/c1-2-3-4-6-13-7-5-8-14(9-13)10-15-11-16-12-17-15/h5,7-9,11-12H,2-3,10H2,1H3,(H,16,17)
InChIKey
JAPGJDHRYBFKBD-UHFFFAOYSA-N
PubChem Compound ID
24825518
Target and Pathway
Target(s) Cytochrome P450 2D6 Target Info Inhibitor [529437]
KEGG Pathway Metabolism of xenobiotics by cytochrome P450
Drug metabolism - cytochrome P450
Serotonergic synapse
Reactome Xenobiotics
WikiPathways Metapathway biotransformation
Tamoxifen metabolism
Oxidation by Cytochrome P450
Vitamin D Receptor Pathway
Aripiprazole Metabolic Pathway
Fatty Acid Omega Oxidation
Codeine and Morphine Metabolism
References
Ref 529437J Med Chem. 2008 May 22;51(10):2944-53. Epub 2008 Apr 24.4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.
Ref 529437J Med Chem. 2008 May 22;51(10):2944-53. Epub 2008 Apr 24.4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.